Vanberra Signal

ClearLight Biotechnologies

Curated by Signal

Provider of tissue processing and digital spatial image analysis platform

Overview

ClearLight Biotechnologies have developed tissue processing and digital spatial image analysis (3D) platform. The platform enables 3D analysis of preclinical and clinical models of disease. It enables multiple interrogations of a single sample to enhance information about 3D biomarkers. They offer services including tissue clearing and immunostaining, multiplexed fluorescence, and 3D image analysis.

Key facts

Founded
2014

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Developer of medical devices to treat chronic and acute sinus infections

    Health TechnologyEffingham, United States
  • Provider of an app to train and change the mindset of users

    Health TechnologyRiverside, United States

About ClearLight Biotechnologies

What does ClearLight Biotechnologies do?

ClearLight Biotechnologies have developed tissue processing and digital spatial image analysis (3D) platform.

Where is ClearLight Biotechnologies headquartered?

ClearLight Biotechnologies is headquartered in Sunnyvale, United States.

When was ClearLight Biotechnologies founded?

ClearLight Biotechnologies was founded in 2014.

Which sector is ClearLight Biotechnologies in?

ClearLight Biotechnologies operates in Health Technology.

Who are ClearLight Biotechnologies's competitors?

Companies similar to ClearLight Biotechnologies include AxioSonic, MINDTAPP, and Navion Healthcare Solutions.